Michael D. Ehlers, EVP, Research and Development at BIOGEN INC. (BIIB), sold 1,000 shares at $350.00 ($350K) on 2018-09-26, disclosed to the SEC on 2018-09-27.
Open-market sale of $350k BIIB by EVP, Research and Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.